Latest filing published 04 Jan 2016 for Lattice Biologics Ltd. (formerly Blackstone Ventures Inc.).
No signal scores available.
All filings by Donald Arthur McInnes on record concern Lattice Biologics Ltd. (formerly Blackstone Ventures Inc.). The record holds 3 filings, all for trades on 31 December 2015.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The newest entry dates from 4 January 2016: a transaction, in Lattice Biologics Ltd. (formerly Blackstone Ventures Inc.). Filings reach the SEDI feed a median of 4 days after the trade. Until a filing is published, the market cannot know about the trade. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations